Sarepta Therapeutics to Present at Upcoming Investor Conferences
Get Alerts SRPT Hot Sheet
Join SI Premium – FREE
CAMBRIDGE, Mass., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at three upcoming virtual investor conferences:
- Credit Suisse 30th Annual Healthcare Conference on Tuesday, November 9, 2021 at 12:10 p.m. E.T.
- Barclays Gene Editing & Gene Therapy Summit 2021 on Monday, November 15, 2021 at 3:00 p.m. E.T.
- Evercore ISI 4th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 1:25 p.m. E.T.
The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.
About Sarepta TherapeuticsSarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.
Internet Posting of InformationWe routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.
Source: Sarepta Therapeutics, Inc.
Investor Contact: Ian Estepan, 617-274-4052[email protected]
Media Contact: Tracy Sorrentino, 617-301-8566[email protected]
Source: Sarepta Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SuperiorMed Holdings Limited Announces Entering into an Agreement and Plan of Merger with Starry Sea Acquisition Corp
- What Is the Best Crypto to Buy in August 2026 Before the Next Listing Changes Everything
- Codeyoung Integrates AI Across Its entire K-12 Curriculum
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Credit Suisse, Barclays, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share